Experimental autoimmune encephalomyelitis (EAE) is a condition induced in some susceptible species to the study of multiple sclerosis (MS). The platelet activating factor (PAF) is an important mediator of immune responses and seems to be involved in MS. However, the participation of PAF in EAE and MS remains controversial. Thus, in this study, we aimed to evaluate the role of PAF receptor in the pathogenesis of EAE. EAE was induced using an emulsion containing MOG . EAE-induced PAF receptor knock out (PAFR Open access under the Elsevier OA license.
Introduction
Multiple sclerosis is considered a classical T-cell-mediated autoimmune disease of the central nervous system (CNS), though its underlying causes remain obscure (McFarland and Martin, 2007) . Most of the current knowledge on the mechanisms of CNS inflammation has been gathered from experimental autoimmune encephalomyelitis (EAE) which is considered an animal model of multiple sclerosis (Gold et al., 2006) . Indeed, several researchers regard EAE as an important tool to explore mechanisms of autoimmunity and inflammation in CNS, ultimately contributing to provide insights for therapeutic strategies (Steinman and Zamvil, 2005; Ransohoff, 2006) . Many mediators are involved in CNS inflammation, such as chemokines, cytokines, Toll-like receptors. Among these, only a few works have investigated the role of platelet activating factor (PAF) in EAE. PAF is a potent and versatile mediator of inflammation that is produced by numerous cell types, especially by leukocytes (Stafforini et al., 2003; Ishii and Shimizu, 2000) . PAF acts on a single receptor (PAFR) that may be expressed on the cellular membrane or the outer leaflet of the nucleus of various cell types, mainly leukocytes, platelets and endothelial cells (Ishii and Shimizu, 2000; Marrache et al., 2002) . Howat et al. (1989) were the first to propose a role for PAF in EAE. Blockade of PAF receptor with CV6209 led to decline in EAE severity (El Behi et al., 2007) . In addition, enzymes involved in the production of PAF are upregulated in the CNS after EAE induction (Kihara et al., 2008) . On the other hand, PCA4248 and WEB2170 antagonists of PAF were not able to suppress the clinical signs of EAE (Vela, 1991) . Even though previous studies in EAE are not in complete agreement, PAF seems to act as a proinflammatory molecule. More recently, it was proposed that PAF plays a dual role in the course of EAE. In the induction phase, PAF would be involved in processes of blood-brain barrier breakdown and induction of the synthesis of inflammatory mediators. In the chronic phase, PAF would be contributing to prevent remission due to loss of phagocytic activity of microglia with the release of cytotoxic mediators such as tumor necrosis factor (TNF)-α (Kihara et al., 2005) .
Thus, in this work, we aimed to investigate the role of PAF in the course of EAE using animals lacking the PAF receptor. We performed intravital microscopy, analysis of cytokines and chemokines in CNS and investigated cellular markers in brain tissue.
Results

Absence of PAF receptor attenuates EAE
WT animals developed EAE with onset of clinical signs after 11 days of immunization and a peak of motor impairment after 14 days of immunization. All WT mice developed signs of weakness and paralysis of both tail and hind limbs and there was a significant weight loss. In contrast, PAFR −/− animals developed a milder disease, with significant lower clinical score (p < 0.01) and delayed onset when compared to WT mice Fig. 2 . In WT animals (n = 4) an inflammatory infiltrate composed predominantly of mononuclear cells ( Fig. 2A and C) was observed. In PAFR −/− animals (n = 4), there was a reduced area of inflammation (Fig. 2D ) which presented mainly eosinophils and neutrophils ( Fig. 2E and F). The infiltrated area was predominantly submeningeal and distributed along vessels that penetrate the spinal cord tissue. There was associated edema and vascular congestion of meninges in both WT and PAFR −/− mice. We also removed brainstem tissue from the same animals to measure N-acetyl-β-D-glucosaminidase (NAG) activity, an index of macrophage sequestration. EAE-induced WT animals present increased NAG activity (OD = 3.27± 0.26) when compared to controls (2.58± 0.07; p < 0.05) and EAE-induced PAFR −/− animals (OD = 2.26 ± 0.13; p < 0.001) (Fig. 3) . There was no difference between EAE-induced PAFR −/− and control PAFR −/− mice.
2.3.
Milder disease in PAFR −/− is independent of rolling and adhesion of leukocytes in CNS microvasculature
To investigate whether PAFR −/− mice presented altered rolling and adhesion of leukocytes in CNS microvasculature, we performed intravital microscopy in the cerebral microvasculature on day 14 post immunization. EAE-induced WT mice presented elevated levels (p < 0.001) of rolling ( Fig. 4A ; cells/min, mean ± SE; 22.42± 3.31) and adhering ( Fig. 4B ; cells/100μm; 7.33± 0.83) cells when compared to control mice (rolling: 0.83± 0.29; adhering: 0.89 ± 0.32). PAFR −/− mice also presented high levels (p < 0.001) of rolling (15.54 ± 2.49) and adhering (7.44 ± 0.71) leukocytes, similar to their WT counterparts but higher than PAFR −/− controls (rolling: 0.67± 0.14; adhering: 0.73± 0.12) (Fig. 4) .
Inflammatory cytokines are not elevated in EAE-induced PAFR −/− mice
We measured cytokines and chemokines known to be involved in EAE. Cytokine IL-17 (pg/100 mg of tissue; mean ± SE; 175.60 ± 
Discussion
In this work, we showed that the absence of PAF receptor attenuates EAE. This better clinical outcome was associated with lower levels of cytokines and reduced mononuclear cell infiltration in the CNS. Interestingly, there was a change in the profile of the inflammatory infiltrate composed mainly of neutrophils and eosinophils, while no alteration in pivotal steps (rolling and adhesion) of cell recruitment was noticed. Also, of great importance, T-helper (Th)17 response seems to be impaired in EAE-induced PAFR −/− mice.
Induction of EAE results in hind limbs paresis and paralysis in WT mice following resolution of disease by recovery of clinical signs. Milder disease in animals lacking the PAF receptor confirmed previous studies investigating PAF in EAE. Kihara et al. (2005) reported diminished disease incidence in PAFR −/− mice and a better recovery of clinical signs. Clinical signs in EAE are elicited due to loss of myelin and axons in CNS tissue (Wujek, et al., 2002) . Mononuclear cells infiltrating the CNS are thought to be the effectors of myelin and axon damage (Zeine and Owens, 1992) . EAE-induced PAFR −/− mice presented fewer mononuclear cells in spinal cords and reduced macrophage sequestration in brainstem when compared to WT animals, suggesting that absence of PAF receptor is impairing recruitment of these cells to CNS. One possibility that could explain lower mononuclear cell infiltration could be diminished rolling and adhesion of these cells in CNS microvasculature. To evaluate rolling and adhesion steps of leukocyte recruitment, we performed intravital microscopy in cerebral microvasculature at the peak of EAE in WT animals. EAE-induced WT animals present increased levels of rolling and adhered leukocytes, as already presented significantly lower NAG levels when compared to WT EAE-induced mice (n = 5). Results are expressed as mean ± SEM, where *p < 0.05 and ***p < 0.001. . Surprisingly, PAFR −/− mice presented similar levels of leukocyte rolling and adhesion when compared to WT mice. Rolling and adhesion are steps of recruitment which depend on the expression of selectins and adhesion molecules and are influenced by the presence of chemokines in tissue (Schenkel et al., 2004 Infiltrating cells synthesize molecules to recruit and activate more cells to invade CNS tissue (Reboldi et al., 2009 ). It has been established that EAE-induced mice present elevated cytokines and chemokines levels in CNS tissue at the peak of EAE (Fife et al., 2001; Juedes et al., 2000; Ambrosini et al., 2003) . We confirmed the presence of high levels of proinflammatory cytokines and chemokines in EAE-induced WT mice. However, PAFR −/− mice presented levels compared to control mice in all cytokines and chemokines measured, suggesting that infiltrating cells in these mice were not synthesizing these molecules. Lack of PAF receptor may be impairing IL-17 release by astrocytes, which were shown to be the source of this cytokine in the onset of EAE clinical signs (Kang et al., 2010) . In addition, lack of mononuclear cells in CNS tissue, which was shown by the diminished number of CD4 + lymphocytes, may result in lower cytokine and chemokine synthesis. Kihara et al. (2005) found a decreased phagocytic activity in PAFR −/− macrophages. Our data suggest that the reduced amount of IL-17 and diminished number of CD4 + cells may account for the reduced phagocytic activity of macrophages lacking PAFR. Th17 response has been shown to be relevant in EAE (Langrish et al., 2005) . To our knowledge, we showed, for the first time, that this response may be impaired in EAEinduced PAFR −/− mice. The need for Th17 responses to induce EAE is still a matter of debate. While some studies consider it to be essential (Kroenke and Segal, 2007) , others claim that it is not necessary (Kroenke, et al., 2010) . We show here an 
Conclusions
In conclusion, we have shown that PAF receptor is important in the induction and development of EAE. Absence of this receptor leads to milder mononuclear cell infiltration, decrease of CD4 + Th17 lymphocytes and lower levels of inflammatory cytokines and chemokines in CNS tissue, but no influence on leukocyte rolling and adhesion.
Experimental procedures
Mice
Female C57BL/6 mice were obtained from Animal Care Facilities of Federal University of Minas Gerais (UFMG, Brazil), aged between 9 and 10 weeks. Female PAFR −/− mice with the same age of C57BL/6 were a kind gift from professor Takao Shimizu (University of Tokyo) and were bred and maintained under SPF conditions at Instituto de Ciências Biológicas. The Animal Ethics Committee of UFMG approved all experimental procedures used (protocol number: 129/2006).
EAE induction and clinical assessment
EAE was induced using an emulsion containing myelin oligodendrocyte glycoprotein (MOG), Complete Freund's Adjuvant (CFA) and attenuated Mycobacterium tuberculosis. Pertussis toxin was injected separately and intraperitoneally. MOG peptide, sequence 35-55 (MEVGWYRSPFSRVVHLYRNGK; Auspep) was obtained from NeoMPS (San Diego, USA). Pertussis toxin and CFA were purchased from Sigma Chemical Co (St. Louis, MO, USA). Attenuated M. tuberculosis H37 RA was purchased from Difco Laboratories (Sparks, MD, USA). Each animal received 100 μL of the emulsion in the base of tail containing 100 μg of MOG . Each animal received two i.p. doses of 300 ng of pertussis toxin in the day of the immunization and 48 h later. Animals were monitored daily and clinical score was evaluated using a standard scoring system. Briefly, the score is characterized as follows: 0 = no signs; 0.5= tail weakness; 1 = tail paralysis; 2 = hind limb weakness; 3 = hind limb paralysis; 4 = hind limb paralysis and front limb weakness. Animals were also weighed daily.
Histopathology
Spinal cords were quickly removed after intravital microscopy and preserved in 10% buffered formalin. The sections (4 μm) were stained with hematoxylin and eosin (H&E) and analyzed for CNS inflammation in an Olympus BX51 microscope.
Measurement of N-acetyl-β-D-glucosaminidase activity
The extent of macrophage sequestration was quantified indirectly by the measuring of N-acetyl-β-D-glucosaminidase (NAG) activity in brain supernatants, as an index of monocyte influx (Lacerda-Queiroz et al., 2010) . In brief, the brains of control and immunized animals (on day 14 post immunization) were removed, weighed and the tissue was homogenized in extraction solution (100 mg of tissue per mL), containing 0.4M NaCl, 0.05% Tween 20, 0.5% BSA, 0.1 mM phenyl methyl sulphonyl fluoride, 0.1 mM benzethonium chloride, 10 mM EDTA and 20 KIU aprotinin, using Ultra-Turrax. Brain homogenate was centrifuged at 3000×g for 10 min at 4°C and the resultant pellet was resuspended in saline/Triton 0.1%. The NAG reaction was run at 37°C for 10 min in a 96-well microplate following the addition of 100 μL p-nitrophenyl-Nacetyl-β-D-glucosaminide (Sigma-Aldrich, St. Louis, MO), dissolved in citrate/phosphate buffer (0.1 M citric acid, 0.1 M Na 2 HPO 4 , pH 4.5) at a final concentration of 2.24 mM. The reaction was terminated by the addition of 100 μL 0.2M glycine buffer (pH 10.6). NAG activity was assayed by measuring the change in absorbance (optical density [OD] ) at 405nm in a spectrophotometer (Emax, Molecular Devices) and interpolated on a standard curve constructed with p-nitrophenol (0-500 nmol/ml) (Sigma-Aldrich). Results were expressed as change in O.D. per gram of tissue.
Intravital microscopy in mouse brain
Intravital microscopy of the mouse cerebromicrovasculature was performed at day 14 post immunization as previously described (Vilela et al., 2008) . Briefly, mice were anesthetized by intraperitoneal injection of a mixture of 150 mg/kg ketamine and 10 mg/kg Xylazine and the tail vein was cannulated for administration of fluorescent dyes. A craniotomy was performed using a high-speed drill (Dremel, USA) and the dura mater was removed to expose the underlying pial vasculature. Throughout the experiment, the mouse was maintained at 37°C with a heating pad (Fine Science Tools Inc., Canada) and the exposed brain was kept moist with an artificial cerebrospinal fluid buffer, an ionic composition in mmol/L: NaCl 132, KCL 2.95, CaCL 2 1.71, MgCL 2 0.64, NaHCO 3 24.6, dextrose 3.71 and urea 6.7, pH 7.4, at 37°C. To observe leukocyte/endothelium interactions, leukocytes were fluorescently labeled by intravenous administration of rhodamine 6G (0.5 mg/kg body weight) and observed using a microscope (Olympus B201, ×20 objective lens, corresponding a 100 μm of area) outfitted with a fluorescent light source (epi-illumination at 510-560 nm, using a 590 nm emission filter). A silicon-intensified camera (Optronics Engineering DEI-470) mounted on the microscope projected the image onto a monitor (Olympus). Rolling leukocytes were defined as white cells moving at a velocity less than that of erythrocytes cells. Leukocytes were considered adherent to the venular endothelium if they remained stationary for 30 s or longer.
Quantification of MCP-1/CCL2, RANTES/CCL5 and IL-17 in CNS
Brain tissue extracts were obtained from control and experimental mice that were sacrificed at 14 days after immunization. Brains were removed after intravital microscopy, and left and right hemispheres were stored on ice. Thereafter, frozen hemispheres were homogenized in extraction solution (100 mg of tissue per 1 mL), containing 0.4 M NaCl, 0.05% Tween 20, 0.5% BSA, 0.1 mM Phenyl methyl sulphonyl fluoride, 0.1 mM benzethonium chloride, 10 mM EDTA and 20 KIU aprotinin, using Ultra-Turrax. Brain homogenate was spun at 12,500×g for 10 min at 4°C and supernatants were collected and stored at − 70°C. The concentration of MCP-1/CCL2 (Monocyte Chemotactic Protein 1/Chemokine C-C motif Ligand 2), RANTES/CCL5 (Regulated upon Activation, Normal T-cell Expressed, and Secreted/Chemokine C-C motif Ligand 5) and IL-17 was determined using ELISA.
CNS-infiltrating leukocyte isolation and staining
After sacrifice, brain was removed from mice and leucocytes were then isolated from the brain by homogenization through a nitex screen into RPMI (Roswell Park Memorial Institute) media. This cell suspension was fractionated using a step gradient consisting of 30% percoll (Sigma, St. Louis, MO) diluted in RPMI layered over 75% percoll diluted in RPMI.
After centrifugation (8000×g), myelin was aspirated off the top of the 30% percol layer. Leucocytes were removed from the interface between the 75% and 30% layers of percoll. Afterwards, leucocytes were centrifuged (600×g) and resuspended in 1 mL of a solution containing 0.5% Bovine Serum Albumin (BSA), 2 mM azide and phosphate-buffered saline (pH 7.4). Leukocytes obtained from CNS tissue were stained with a combination of fluoresceine isothiocyanate (FITC) and phycoerythrin (PE) labeled antibodies directed against surface molecule CD4 and intracellular molecule IL-17, respectively. Data were acquired using a FACScan (Becton Dickinson, San José, CA, USA) and raw data of FACS analysis were processed using the Cell Quest software (Becton Dickinson, San José, CA, USA). Collected flow cytometry data were analyzed using FlowJo software (Tree Star, Ashland, Oregon, USA) (Fig. 6 ).
Statistical analysis
Data are shown as mean± SEM. ANOVA parametric test with Bonferroni correction was used for multiple comparisons. For Results were expressed as the mean ± SEM. Statistically significant differences were indicated by *p < 0.05 and **p <0.01.
